Elevated levels of systemic inflammatory markers, such as interleukin-1β, interleukin-6, tumor necrosis factor-alpha, and C-reactive protein, have been reported in both patients with PD and animal models [26,27]. This evidence concerns the gene IL6 and Parkinson disease.